Acute-on-chronic liver failure (ACLF) carries a significant burden on critical care services and health care resources. However, the exact pathogenesis of ACLF remains to be elucidated, and novel treatments are desperately required. In our previous work, we utilized mice subjected to acute insult in the context of hepatic fibrosis to simulate the development of ACLF and documented the favorable hepatoprotection conferred by M2-like macrophages in vivo and in vitro.
Introduction
Acute-on-chronic liver failure (ACLF) occurs in the setting of chronic liver diseases, and exacerbates after precipitating events such as acute viral, drug, or alcoholic hepatic insults. 1, 2 In comparison, acute liver failure (ALF) occurs most often in patients who do not have pre-existing liver diseases. 3, 4 Subjectively thinking, ACLF patients would suffer from more severe hepatic damage than ALF patients. Instead, ACLF has a relatively lower mortality. 5 This phenomenon coincides with the previous report that patients with prior hepatic decompensation have lower short-term mortality than those without prior decompensation. 5, 6 Herein, previous decompensation may be considered as a beneficial response instead of deleterious event. Moreover, there is a crucial "golden window" period preceding sepsis development and organ failure in ACLF, which provides the valuable opportunity for reversing progressive liver failure through therapeutic interventions. 6, 7 This motivates us to decipher the underlying mechanisms governing the favorable protection against acute insult in ACLF.
We and others have attempted to explore this issue. Considering that currently there is no canonical mouse model of ACLF, researchers utilize mice subjected to acute insult in the context of hepatic fibrosis to simulate the development of ACLF. In this regard, hepatic fibrosis induced by carbon tetrachloride (CCl 4 ), bile duct ligation (BDL), and thioacetamide (TAA) has been demonstrated to exert the hepatoprotective effects against various acute insults including D-galactosamine/LPS (D-GalN/LPS), 8 acetaminophen (APAP), 9 CCl 4 , 10 and TNF-a/Fas-induced apoptosis. [11] [12] [13] At the cellular level, innate immune cells, especially macrophages, are considered as the major contributor to injury resistance in the fibrosis setting. The outstanding study by Osawa et al. has specifically addressed the role of Kupffer cells (KCs), 12 the hepatic resident macrophages, in the cholestatic liver injury using mice subjected to partial bile duct ligation (PBDL). They found that KC-derived acid sphingomyelinase (ASMase) is crucial for the protective and regenerative effects of Akt activation in ligated lobes (fibrotic). Our previous work elucidated this issue from a novel perspective, namely, macrophage activation. Our data showed macrophages assume the important but divergent roles in acute injury and hepatic fibrosis. The dichotomous functions of macrophages can be ascribed to their phenotypic heterogeneity: M1-like macrophages in acutely injured mice promote hepatic injury, whereas M2-like macrophages in the fibrotic liver confer mice the great resistance against insults. 10 In our latest in vitro study, we dissected the underlying mechanism by which M2-like macrophages potentially exert a protective effect on injury resistance occurring in the setting of hepatic fibrosis. As a result, M2-like macrophages promote the apoptosis of M1-like macrophages, but protect hepatocytes against apoptosis, thus leading to the development of injury resistance. 14 As we all know, macrophage polarization is mainly modulated by local microenvironmental signals. Most importantly, macrophage activation is a highly dynamic process, and the phenotype of polarized macrophages can be reversed under physiological and pathological conditions. [15] [16] [17] In this regard, modulation of macrophage activation to acquire desirable phenotype and function may provide promising therapies to promote tissue repair. [18] [19] [20] [21] To prove this supposition, our in vitro experiment will focus on the phenotypic switch of macrophages in response to different stimuli and assess the effect of this switch on hepatocyte apoptosis. To be specific, polarized human and mouse macrophages were reprogrammed, then conditioned medium experiments were conducted followed by apoptosis induction. The apoptosis resistance of human and mouse hepatocytes were compared before and after phenotypic switch of macrophages.
Our findings help advance the understanding of the pathogenesis of ACLF and will shed light on a novel therapeutic intervention through manipulating macrophage polarization.
Materials and methods

Animals
Male BALB/c mice (6-8 wk old) were obtained from Laboratory Animal Center, Academy of Military Medical Sciences, Beijing, China. Mice were housed in a specific pathogen-free (SPF) environment at [22] [23] [24] C with alternatively 12 h light-dark cycles. Animals were fed standard laboratory chow with free access to water. All animal care and experimental procedures performed in this study were in accordance with the Guide for the Care and Use of Laboratory Animals and approved by Institutional Animal Care and Use Committee at Beijing YouAn Hospital affiliated to Capital Medical University.
Reverse transcription (RT) and SYBR Green real-time quantitative PCR (qPCR) 8 Total RNA was extracted from isolated macrophages using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's instructions. Reverse transcription of the purified RNA (2 lg) was performed using random primers and AMV retrotranscriptase system (TakaRa, Dalian, Liaoning, China) according to the manufacturer's protocol. SYBR Green real-time PCR was carried out using the ABI StepOne Plus (Applied Biosystems, Foster City, CA, USA). All reactions were performed in triplicate. The primers used were designed with Primer 3.0 software and listed in Table 1 . The relative expression of target genes was calculated and normalized to the expression of GAPDH, a housekeeping gene.
Isolation and in vitro polarization of primary mouse macrophages
Primary mouse macrophages (see Figure 1) were isolated from the livers of mice by pronase (Roche Diagnostics GmbH, Mannheim, Germany) and collagenase (Sigma-Aldrich, St. Louis, MO, USA) digestion followed by differential centrifugation using our previously reported method. 10 Isolated macrophages (nonpolarized M0 macrophages) were stimulated with mouse recombinant IFN-c (100 U/ml, PeproTech, Rocky Hill, USA) or IL-4 (10 ng/ml, PeproTech). Twenty-four h later, parts of M(IFN-c) or M(IL-4) macrophages were exposed to IL-4 or IFN-c stimulation, respectively, for another 24 h. In other words, mouse macrophages were divided into five groups: M0, M(IFN-c), M(IFN-c!IL-4), M(IL-4), and M(IL-4!IFN-c). The phenotype of the subsets was identified through qRT-PCR analysis for gene signatures of representative markers. 10, [22] [23] [24] [25] In addition, supernatants from all subsets were collected for conditioned medium experiment.
Isolation, culture, and polarization of human monocyte-derived macrophages PBMCs were isolated from the whole blood of healthy donors and ACLF patients using a Ficoll (Hao Yang Biological Manufacture Co. Ltd., Tian Jin, China) density gradient, and cultured in DMEM supplemented with 10% FBS. Two h later, non-adherent cells were removed, 26 and the resultant adherent cells (monocytes) were cultured in DMEM supplemented with human recombinant macrophage colony-stimulating factor (M-CSF, 50 ng/ml, PeproTech) for 6 d. Differentiated macrophages (non-polarized macrophages) were polarized with human recombinant IFN-c (50 ng/ml, Peprotech) or IL-4 (50 ng/ml, Peprotech). Similarly to mice, parts of M(IFN-c) or M(IL-4) macrophages derived from PBMCs of healthy donors were exposed to IL-4 or IFN-c stimulation, respectively, for another 24 h. As mentioned above, human macrophages were also divided into five groups, and the phenotype of the subsets was identified through qRT-PCR analysis. 10, 14 Supernatants from all subsets were also collected for conditioned medium experiment.
Conditioned medium experiments and apoptosis detection
Conditioned media (CMs) from human and mouse macrophages, i.e., M0 CM, M(IFN-c) CM, M(IFNc!IL-4) CM, M(IL-4) CM, and M(IL-4!IFN-c) CM were collected and centrifuged to remove cell debris. Then, CMs from above-mentioned groups were incubated with primary mouse hepatocytes or human liver cell lines (HL-7702 and HepG2) for 6 h, and then cell apoptosis was induced by human and mouse TNF-a (50 lg/ml, Peprotech)/D-GalN (100 mg/ml, Sigma-Aldrich) (GA for short) for 12 h. 27, 28 To evaluate hepatocyte apoptosis, primary mouse hepatocytes and HL-7702/HepG2 cells were stained with rabbit anti-mouse cleaved caspase-3 (Abcam, Cambridge, MA, USA) and FITC-conjugated goat anti-rabbit IgG (eBioscience, San Diego, CA, USA). A Nikon Inverted Fluorescence Microscope ECLIPSE Ti and NIS-Elements F3.0 Software (Nikon Corporation, Tokyo, Japan) was applied for image capture. Image J software was used to quantify the expression of cleaved caspase-3.
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Cell culture
Human liver cell lines (HL-7702 and HepG2), primary mouse hepatocytes and isolated mouse/human macrophages were cultured in DMEM (Gibco, Grand Island, NY, USA) supplemented with 10% heat-inactivated FBS (Gibco) and 1% penicillin/streptomycin (Gibco) in a 37 C incubator.
Statistical analysis
Results were expressed as mean AE SEM. Group comparisons were performed using Student's t test or one-way ANOVA followed by Newman-Keuls multiple comparison test. Statistics and graphs were generated using Prism 5.0 software (GraphPad Software Inc., San Diego, CA, USA). P < 0.05 was considered statistically significant.
Results
The phenotypic switch of mouse macrophages in vitro 
Skewing macrophages toward M(IL-4) phenotype confers human hepatocytes enhanced apoptosis resistance
We also assessed the effects of phenotypic switch of polarized human PBMC-derived macrophages on Figure 7) . Thereby, macrophages from ACLF patients can also be reprogrammed in response to diverse stimuli.
Discussion
ACLF is an increasingly recognized entity which carries a significant burden on critical care services and health care resources. However, the exact pathogenesis of ACLF remains to be elucidated, and novel treatments are desperately required 1 . In recent years, we have endeavored to investigate the pathogenesis of ACLF, and focus on injury resistance in the setting of hepatic fibrosis (simulating the development of ACLF). We previously have documented the favorable protection against apoptosis conferred by M2-like macrophages in mice (in vivo and in vitro) and humans (in vitro). 10, 14 In the present work, we highlight the phenotypic switch of human and mouse macrophages and the effect of this switch on hepatocyte apoptosis. We show that macrophages derived from PBMCs of healthy donors and murine liver, even PBMCs of patients with ACLF, can be re-programmed and shape their phenotype in response to diverse microenvironmental cues. Most importantly, we provide powerful evidence that skewing macrophages toward an M(IL-4) phenotype confers hepatocytes enhanced resistance to apoptosis in human and mice. In view of the dynamics and complexity of macrophage activation, study on phenotypic switch of macrophages, especially the phenotypic switch occurring in macrophages derived from ACLF patients, is required and clinically relevant. ACLF is an innate immune-driven disorder, in which monocytes/macrophages are key determinants of the initiation, propagation, and resolution of liver injury. [29] [30] [31] Macrophages inherently display tissue and environment-dependent plasticity, which means the same macrophages may have a variety of functions depending on the local tissue environment during different stages of disease. 32, 33 Macrophages are coarsely classified into two subsets: M1 macrophages and M2 macrophages. M1 macrophages are activated by pathogens or toxins (such as LPS), and secrete proinflammatory mediators which induces inflammation and liver damage; conversely, M2 macrophages are activated by IL-4/IL-13, and release antiinflammatory or pro-resolving mediators which mediates wound repair, tissue remodeling and fibrosis. 16, 34 Macrophages in vivo adopt a mixed phenotype between M1-and M2-type macrophages. The M1/M2 balance is regarded as a decisive factor for macrophage function. 31, 35 Nevertheless, the classification of "M1" or "M2" macrophages is too simplistic to reflect the complexity of macrophage activation. Therefore, in this in vitro study, we nominate macrophages in response to IFN-c stimulation as M(IFN-c) and those upon IL-4 stimulation as M(IL-4), according to the nomenclature for macrophage activation proposed by Murray et al. 36 We previously have documented the favorable protection conferred by M2-like macrophages in mice and human. In view of the great plasticity of macrophages, we extend our work from macrophage activation to In sum, our data further demonstrate the favorable protection of M(IL-4) macrophages from the viewpoint of phenotypic switch. Although our data are preliminary, it still provides evidence, at least in part, for the immune-modulating therapy of ACLF patients through re-orientating macrophages to acquire the desirable functions.
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